The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure

1. Rouhi, L.
2. Fan, S.
3. Cheedipudi, S.M.
4. Braza-Boïls, A.
5. Molina, M.S.
6. Yao, Y.
7. Robertson, M.J.
8. Coarfa, C.
9. Gimeno, J.R.
10. Molina, P.
11. Gurha, P.
12. Zorio, E.
13. Marian, A.J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/CVR/CVAB197 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus